Inhibition of Th2-mediated allergic airway inflammatory disease by CD137 costimulation

Journal of Immunology

Volumn 177, Issue 2, 2006, Pages 814-821

  Sun, Yonglian ^a   Blink, Sarah E ^a   Liu, Wenhua ^a   Lee, Youjin ^a   Chen, Bohao ^a   Solway, Julian ^a   Weinstock, Joel ^b   Chen, Lieping ^c   Fu, Yang Xin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD137 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY DISEASE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHISTOSOMA MANSONI; SENSITIZATION; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TUMOR IMMUNITY; VIRUS IMMUNITY;

EID: 33745842255     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.2.814     Document Type: Article

References (50)

1. Pollok, K. E., Y. J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-1BB: analysis of expression and function. J. Immunol. 150: 771-781.
2. Kwon, B. S., and S. M. Weissman. 1989. cDNA sequences of two inducible T cell genes. Proc. Natl. Acad. Sci. USA 86: 1963-1967.
3. Melero, I., J. V. Johnston, W. W. Shufford, R. S. Mittler, and L. Chen. 1998. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell Immunol. 190: 167-172.
4. Kwon, B., C. H. Moon, S. Kang, S. K. Seo, and B. S. Kwon. 2000. 4-1BB: still in the midst of darkness. Mol. Cells 10: 119-126.
5. + suppressor T cells in vivo. Nat. Immunol. 3: 33-41.
6. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
7. Futagawa, T., H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, and K. Okumura. 2002. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14: 275-286.
8. Wilcox, R. A., A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Shin, D. B. Flies, K. Tamada, R. S. Mittler, H. Tsuchiya, D. M. Pardoll, and L. Chen. 2002. Cutting edge: expression of functional CD137 receptor by dendritic cells. J. Immunol. 168: 4262-4267.
9. Goodwin, R. G., W. S. Din, T. Davis-Smith, D. M. Anderson, S. D. Gimpel, T. A. Sato, C. R. Maliszewski, C. I. Brannan, N. G. Copeland, N. A. Jenkins, et al. 1993. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23: 2631-2641.
10. Pollok, K. E., Y. J. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24: 367-374.
11. Alderson, M. R., C. A. Smith, T. W. Tough, T. Davis-Smith, R. J. Armitage, B. Falk, E. Roux, E. Baker, G. R. Sutherland, and W. S. Din. 1994. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24: 2219-2227.
12. Hurtado, J. C., Y. J. Kim, and B. S. Kwon. 1997. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158: 2600-2609.
13. Takahashi, C., R. S. Mittler, and A. T. Vella. 1999. Cutting edge: 4-1BB is a bonafide CD8 T cell survival signal. J. Immunol. 162: 5037-5040.
14. + cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J. Immunol. 169: 4230-4236.
15. + regulatory T cells. J. Immunol. 173: 2428-2434.
16. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186: 47-55.
17. Melero, I., W. W. Shuford, S. A. Newby, A. Aruffo, J. A. Ledbetter, K. E. Hellstrom, R. S. Mittler, and L. Chen. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3: 682-685.
18. Blazar, B. R., B. S. Kwon, A. Panoskaltsis-Mortari, K. B. Kwak, J. J. Peschon, and P. A. Taylor. 2001. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J. Immunol. 166: 3174-3183.
19. + T cell responses. Nat. Immunol. 3: 536-541.
20. + T cells. Blood 105:2206-2213.
21. Mittler, R. S., T. S. Bailey, K. Klussman, M. D. Trailsmith, and M. K. Hoffmann. 1999. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J. Exp. Med. 190: 1535-1540.
22. Sun, Y., S. E. Blink, J. H. Chen, and Y. X. Fu. 2005. Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling. J. Immunol. 175: 884-890.
23. Sun, Y., X. Lin, H. M. Chen, Q. Wu, S. K. Subudhi, L. Chen, and Y. X. Fu. 2002. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J. Immunol. 168: 1457-1465.
24. Sun, Y., H. M. Chen, S. K. Subudhi, J. Chen, R. Koka, L. Chen, and Y. X. Fu. 2002. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat. Med. 8: 1405-1413.
25. 1 mice. J. Clin. Invest. 111: 1505-1518.
26. Foell, J. L., B. I. Diez-Mendiondo, O. H. Diez, U. Holzer, P. Ruck, A. S. Bapat, M. K. Hoffmann, R. S. Mittler, and G. E. Dannecker. 2004. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance. Immunology 113: 89-98.
27. Seo, S. K., J. H. Choi, Y. H. Kim, W. J. Kang, H. Y. Park, J. H. Suh, B. K. Choi, D. S. Vinay, and B. S. Kwon. 2004. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10: 1088-1094.
28. Shao, H., Y. Fu, T. Liao, Y. Peng, L. Chen, H. J. Kaplan, and D. Sun. 2005. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. Invest. Ophthalmol. Vis. Sci. 46: 596-603.
29. Cohn, L., J. A. Elias, and G. L. Chupp. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22: 789-815.
30. Elias, J. A., C. G. Lee, T. Zheng, B. Ma, R. J. Homer, and Z. Zhu. 2003. New insights into the pathogenesis of asthma. J. Clin. Invest. 111: 291-297.
31. + Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J. Immunol. 148: 2283-2290.
32. Tesciuba, A. G., S. Subudhi, R. P. Rother, S. J. Faas, A. M. Frantz, D. Elliot, J. Weinstock, L. A. Matis, J. A. Bluestone, and A. I. Sperling. 2001. Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease. J. Immunol. 167: 1996-2003.
33. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162: 2477-2487.
34. Wilcox, R. A., D. B. Flies, G. Zhu, A. J. Johnson, K. Tamada, A. I. Chapoval, S. E. Strome, L. R. Pease, and L. Chen. 2002. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J. Clin. Invest. 109: 651-659.
35. Metwali, A., D. Elliott, A. Blum, and J. V. Weinstock. 1996. What models of granulomatous inflammation provide the immunologist? Methods 9: 305-310.
36. Elliott, D. E. 1996. Methods used to study immunoregulation of schistosome egg granulomas. Methods 9: 255-267.
37. Kang, H. S., R. K. Chin, Y. Wang, P. Yu, J. Wang, K. A. Newell, and Y. X. Fu. 2002. Signaling via LTβR on the lamina propria stromal cells of the gut is required for IgA production. Nat. Immunol. 3: 576-582.
38. Lukacs, N. W., R. M. Stricter, S. W. Chensue, and S. L. Kunkel. 1994. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 10: 526-532.
39. Cohn, L., R. J. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin-4 in cell recruitment but not mucus production. J. Exp. Med. 186: 1737-1747.
40. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201.
41. Coyle, A. J., K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews, and C. Heusser. 1996. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183: 1303-1310.
42. Maddox, L., and D. A. Schwartz. 2002. The pathophysiology of asthma. Annu. Rev. Med. 53: 477-498.
43. Kang, H. S., S. E. Blink, R. K. Chin, Y. Lee, O. Kim, J. Weinstock, T. Waldschmidt, D. Conrad, B. Chen, J. Solway, et al. 2003. Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation. J. Exp. Med. 198: 1643-1652.
44. Murphy, K. M., and S. L. Reiner. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2: 933-944.
45. Lee, S. W., A. T. Vella, B. S. Kwon, and M. Croft. 2005. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J. Immunol. 174: 6803-6808.
46. Li, Q., A. Carr, F. Ito, S. Teitz-Tennenbaum, and A. E. Chang. 2003. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy. Cancer Res. 63: 2546-2552.
47. Kim, Y. J., S. H. Kim, P. Mantel, and B. S. Kwon. 1998. Human 4-1BB regulates CD28 costimulation to promote Th1 cell responses. Eur. J. Immunol. 28: 881-890.
48. Maerten, P., B. S. Kwon, C. Shen, G. De Hertogh, P. Cadot, D. M. Bullens, L. Overbergh, C. Mathieu, G. Van Assche, K. Geboes, et al. 2006. Involvement of 4-1BB (CD137)- 4-1BB ligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis. Clin. Exp. Immunol. 143: 228-236.
49. Fukushima, A., T. Yamaguchi, W. Ishida, K. Fukata, R. S. Mittler, H. Yagita, and H. Ueno. 2005. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice. J. Immunol. 175: 4897-4903.
50. Zhu, J., H. Yamane, J. Cote-Sierra, L. Guo, and W. E. Paul. 2006. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 16: 3-10.